$Bob's and Jbem's Bitchin' Bios

[jbem777]

JBEM777- TNXP PLAY & Trading Update7-29-2015

I have decided to provide bi-weekly updates on my current trading positions and thoughts. Things can change quickly in biotech and I think it is best to keep everyone informed.

I have re-entered TNXP as a Play. Cash from the recent offering, trial completion in August, and data release in Q4 for tension headache will definitely provide momentum and draw investor interest. Any drop below $8 has been quickly purchased by investors and the significant decrease in selling volume suggests that the bottom is in. This is further reinforced by the chart and candlesticks. Me entry is in the low $8’s.

Tonix also today announced an update on Study F203, an ongoing, 12-month, open-label extension study of TNX-102 SL taken daily at bedtime. Patients who successfully completed the BESTFIT study could optionally enroll into this open-label study. Of the 174 patients who completed BESTFIT, 158 (91%) enrolled into Study F203. Of these 158 patients, 108 (68%) completed at least six months in Study F203. This study is expected to complete in August 2015.

"Our findings that TNX-201 selectively modulates a receptor in the central nervous system that appears to regulate pain perception and responses, together with positive data in two rodent models representative of migraine, support the development of TNX-201 as a therapeutic for headache and potentially other pain indications and one that may be differentiated from currently-approved products," said Bruce Daugherty, Ph.D., Tonix's chief scientific officer. "We look forward to reporting the results of our Phase 2 POC study in episodic tension-type headache in the fourth quarter of this year."

I currently hold a full position in RPRX. Upcoming catalysts should continue to drive share price. It will have its ups and downs, which I believe will provide excellent trading opportunities. I will add on any dips below $7.30.

SNGX has performed poorly and the price action yesterday and today has triggered the stop loss order on much of my position. I added to my position when it was in the $2.20-2.40's, which did not work out as well as I planned. There comes a point when you must take your loses and evaluate the “opportunity cost” of continuing to hold. I believe my chances of regaining my losses are better in other stocks rather than waiting for SNGX to rebound. I believe that there were a number of factors that led to the poor performance of this stock and I continue to critically evaluate the Pick in order to improve my processes. If it does drop to the $1.50’s again, I may look to add to my remaining shares. I do believe that it will work its way back into the $2 range in the future. The catalysts and data releases are still yet to come and I believe that those should drive value. If there is one thing I learned with SNGX, it’s that it is very unpredictable, but that comes with being on the OTC.

Sometimes you just have to take it on the chin and learn what you can from the trade. I hope this shows many that even despite my knowledge, poor Picks or Plays will be made. To counter this, steps should be taken to maximize the gains and minimize the losses. I use stop loss orders to take the emotion out of selling for a loss and it helps me adhere to my trading strategy.

Past Plays and Upcoming Ideas:

Congrats to AVXL longs! You guys have made some excellent returns in the last few weeks. Don’t forget to take profits though, as any stock will have it’s ups and downs. I am watching this stock closely and I believe any pullback could provide an excellent opportunity to re-enter. From my understanding there will be more data in the coming months that should help propel the share price. Some have asked me about what I thought about the data that was recently released. I think it bodes well for the company, but anecdotal evidence only carries so much weight. I look forward to more data with actual p values to determine the level of significance that was observed. This will be the big value driver.

I am closely watching TPIV. I am unaware of any significant value drivers for TPIV at this time, but haven’t had much time to research.

I am also working on another Pick that will be released in the coming weeks.

Please email me at jbem777@gmail with any questions.

Good trading to you all.